<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01516658</url>
  </required_header>
  <id_info>
    <org_study_id>TRIBRAIN1119</org_study_id>
    <secondary_id>UMIN000006748</secondary_id>
    <nct_id>NCT01516658</nct_id>
  </id_info>
  <brief_title>HYdrogel Coil Versus Bare Platinum Coil in Recanalization Imaging Data Study</brief_title>
  <acronym>HYBRID</acronym>
  <official_title>Efficacy of Hydrogel Coil on Endovascular Treatment for Intracranial Aneurysms; Multi-center, Prospective, Randomized, Open-label Blind-endpoint Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kobe City General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Kobe City General Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      HYBRID study is prospective randomized open label controlled multi center trial, to compare
      Hydrocoil and bare platinum coil for recanalization after endovascular treatment of
      intracranial aneurysms.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      At least one Hydrocoil have to use in Hydrocoil arm, and only bare platinum coil have to use
      in Control arm.

      Primary endpoint is recanalization within 1 year after embolization, and secondary endpoint
      are:

        1. aneurysmal rupture within 1 year after embolization

        2. any event within 30 days after embolization

        3. recanalization within 6 months after embolization

        4. aneurysmal retreatment within 1 year after embolization

        5. aneurysmal rupture and any death within 1 year after embolization

        6. any stroke within 1 year after embolization

        7. any stroke, death hemorrhagic event, aneurysmal recanalization or retreatment within 1
           year after embolization

        8. change in aneurysmal occlusion

        9. any comlicaion within 1 year after embolization

       10. %length of Hydrocoil, maximum diameter of aneurysm, volume embolization ratio.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">June 2012</start_date>
  <completion_date type="Anticipated">September 2018</completion_date>
  <primary_completion_date type="Actual">March 2017</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>recanalization within 1 year after embolization</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>aneurysmal rupture within 1 year after embolization</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>any event within 30 days after embolization</measure>
    <time_frame>30 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>aneurysmal retreatment within 1 year after embolization</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>aneurysmal rupture and any death within 1 year after embolization</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>any stroke within 1 year after embolization</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>any stroke, death hemorrhagic event, aneurysmal recanalization or retreatment within 1 year after embolization</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change in aneurysmal occlusion</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>any complicaion within 1 year after embolization</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">431</enrollment>
  <condition>Intracranial Aneurysm</condition>
  <condition>Subarachnoid Hemorrhage</condition>
  <arm_group>
    <arm_group_label>Hydrogel coil group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>use Hydrogel Coil as much as be able to use</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Bare platinum coil group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>use only bare platinum coil</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Hydrogel coil</intervention_name>
    <description>at least one Hydrogel coil have to use for embolization</description>
    <arm_group_label>Hydrogel coil group</arm_group_label>
    <other_name>Hydrocoil</other_name>
    <other_name>HydroSoft</other_name>
    <other_name>HydroFrame</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Bare platinum coil</intervention_name>
    <description>only bare platinum coil have to use for embolization</description>
    <arm_group_label>Bare platinum coil group</arm_group_label>
    <other_name>detachable coil</other_name>
    <other_name>GDC</other_name>
    <other_name>Microvention</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  saccular intracranial aneurysm

          -  endovascular treatment scheduled within 60days after consent

          -  20-79 years old

          -  unruptured, chronic SAH or acurte SAH Grade 1-III

          -  7-20mm in size

          -  1 year follow up possibel

          -  independent (mRS 0-2)

          -  document consent

        Exclusion Criteria:

          -  previous endovascular treated

          -  additional aneurysm scheduled of endovascular treatment

          -  pregnant

          -  ineligible for study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>79 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nobuyuki Sakai, MD, DMSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kobe City Medical Center General Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Nakamura Memorial Hospital</name>
      <address>
        <city>Sapporo</city>
        <state>Hokkaido</state>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kobe City General Hospital</name>
      <address>
        <city>Kobe</city>
        <state>Hyogo</state>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Japan</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 29, 2011</study_first_submitted>
  <study_first_submitted_qc>January 24, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 25, 2012</study_first_posted>
  <last_update_submitted>March 5, 2018</last_update_submitted>
  <last_update_submitted_qc>March 5, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 7, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kobe City General Hospital</investigator_affiliation>
    <investigator_full_name>Nobuyuki Sakai</investigator_full_name>
    <investigator_title>Director of Neurosurgery</investigator_title>
  </responsible_party>
  <keyword>intracranial aneurysm</keyword>
  <keyword>endovascular therapy</keyword>
  <keyword>detachable coil</keyword>
  <keyword>recanalization</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemorrhage</mesh_term>
    <mesh_term>Aneurysm</mesh_term>
    <mesh_term>Subarachnoid Hemorrhage</mesh_term>
    <mesh_term>Intracranial Aneurysm</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

